A treatment strategy for KRAS-driven tumors

Nat Med. 2018 Jul;24(7):902-904. doi: 10.1038/s41591-018-0111-x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Humans
  • Lung Neoplasms*
  • Proto-Oncogene Proteins p21(ras)*

Substances

  • KRAS protein, human
  • Proto-Oncogene Proteins p21(ras)